A-Alpha Bio
Total Raised
$64.25MInvestors Count
18Funding, Valuation & Revenue
15 Fundings
A-Alpha Bio has raised $64.25M over 15 rounds.
A-Alpha Bio's latest funding round was a Grant - IX for $14.5M on May 21, 2024.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/21/2024 | Grant - IX | $14.5M | 2 | |||
7/25/2023 | Series A - II | $22.4M | 2 | |||
5/16/2023 | Grant - VIII | $2.4M | 1 | |||
1/1/2022 | Grant - VII | |||||
9/8/2021 | Series A |
Date | 5/21/2024 | 7/25/2023 | 5/16/2023 | 1/1/2022 | 9/8/2021 |
|---|---|---|---|---|---|
Round | Grant - IX | Series A - II | Grant - VIII | Grant - VII | Series A |
Amount | $14.5M | $22.4M | $2.4M | ||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 | 2 | 1 |
A-Alpha Bio Investors
18 Investors
A-Alpha Bio has 18 investors. U.S. Department of Defense invested in A-Alpha Bio's Grant - IX funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/1/2022 | 5/21/2024 | 3 Grant - VII, Grant - VIII (2023), Grant - IX (2024) | Government | DC | ||
9/24/2019 | 7/25/2023 | 3 Seed VC, Series A (2021), Series A - II (2023) | Venture Capital | Washington | ||
9/8/2021 | 7/25/2023 | 2 Series A, Series A - II (2023) | Hedge Fund | New York | ||
Venture Capital | California | |||||
Corporate Venture | Washington |
First funding | 1/1/2022 | 9/24/2019 | 9/8/2021 | ||
|---|---|---|---|---|---|
Last Funding | 5/21/2024 | 7/25/2023 | 7/25/2023 | ||
Investor | |||||
Rounds | 3 Grant - VII, Grant - VIII (2023), Grant - IX (2024) | 3 Seed VC, Series A (2021), Series A - II (2023) | 2 Series A, Series A - II (2023) | ||
Board Seats | |||||
Type | Government | Venture Capital | Hedge Fund | Venture Capital | Corporate Venture |
Location | DC | Washington | New York | California | Washington |
Compare A-Alpha Bio to Competitors
Beckman Coulter Diagnostics provides diagnostic laboratory solutions. It offers products and services including clinical testing equipment, lab automation technologies, and clinical informatics to assist healthcare professionals in delivering patient care. Its solutions aim to improve the operations of diagnostic laboratories in healthcare settings. Beckman Coulter Diagnostics was formerly known as Beckman Instruments. It was founded in 1935 and is based in Brea, California.
Cyclofluidic is a biotechnology company focused on biopharmaceutical research tools and supplies. The company offers products such as reagents and kits for protein analysis, cell viability assays, and rRNA depletion. These products support mRNA vaccine development, protein analysis, and various biotechnological research applications. It was founded in 2008 and is based in Herts, England.
Actome is a biotechnology company specializing in the highly sensitive detection and quantification of proteins, protein interactions, and post-translational modifications within the life sciences sector. The company's main offerings include their proprietary Protein Interaction Coupling (PICO) technology and related products and services, which translate protein status into DNA barcodes for analysis using digital PCR technology. Actome's solutions cater to the needs of the biomedical research and pharmaceutical industries, providing tools for protein biomarker detection, cellular pathway analysis, and innovative research applications. It was founded in 2016 and is based in Freiburg, Germany.
Spectroswiss specializes in advancing mass spectrometry technologies within the life, environmental, and basic sciences sectors. The company offers comprehensive tools for processing and analyzing mass spectra and time-domain transients, as well as add-on data acquisition systems to enhance the performance of specific mass spectrometry instruments. Spectroswiss also provides expert services including training, research and development, and contract protein analysis. It was founded in 2014 and is based in Lausanne, Switzerland.
CompanDX is a company focused on gene signaling research within the biomedical sector. It specializes in the study of apoptosis and the development of diagnostic tests for cancer. The company primarily serves sectors that require advanced research laboratory services, including academia and pharmaceutical research. CompanDX was formerly known as Compandia. It is based in Nottingham, England.
Mosaic Biosciences is a biologics discovery contract research organization (CRO) that focuses on complex antibody and protein therapeutics. The company offers services such as antibody discovery and optimization, protein design and engineering, cell-based assays, protein sciences and analytics, and pharmacology support. Mosaic primarily serves the biopharmaceutical sector, providing discovery programs to aid in the development of drug candidates. It was founded in 2009 and is based in Boulder, Colorado.
Loading...